Company intelligence / Profile preview
Hebei Bio-High Technology Development
- Ownership
- Private
- Development stage
- Other
Overview
Bio-High is a modern biological high-tech enterprise with integrated R&D, manufacturing and sales of life science products. The company has original technology and a large number of achievements and products used in cellular research and diagnostics. It has contributed to the development of multi-targeting drugs and vaccines[1][2]. The company was involved in the rapid development and donation of COVID-19 antibody detection test papers during the pandemic[2].
- Modalities
- VaccineSmall moleculeBiologic
- Industry
- Biotech
Drug pipeline
6 assets5 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Hebei Bio-High Technology Development.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hebei Bio-High Technology Development.